当前位置: 首页 > 期刊 > 《上海医药》 > 2017年第15期 > 正文
编号:13086709
肿瘤干细胞研究进展(5)
http://www.100md.com 2017年10月8日 《上海医药》2017年第15期
     [17] Krause M, Dubrovska A, Linge A, et al. Cancer stem cells: radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments[J]. Adv Drug Deliv Rev, 2017, 109: 63-73.

    [18] Takebe N, Miele L, Harris PJ, et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update[J]. Nat Rev Clin Oncol, 2015, 12(8): 445-464.

    [19] Duchartre Y, Kim YM, Kahn M. The Wnt signaling pathway in cancer[J]. Crit Rev Oncol Hematol, 2016, 99: 141-149.

    [20] Le PN, Mcdermott JD, Jimeno A. Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28[J]. Pharmacol Ther, 2015, 146: 1-11.

    [21] Takebe N, Nguyen D, Yang SX. Targeting notch signaling pathway in cancer: clinical development advances and challenges[J]. Pharmacol Ther, 2014, 141(2): 140-149.

    [22] Justilien V, Fields AP. Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells[J]. Clin Cancer Res, 2015, 21(3): 505-513. (喻敏成 徐泱)
上一页1 2 3 4 5